Recent Company News

• 09:51 PM ET Apr 10, 2025
  

  StreetAccount Summary - Trading higher/lower: Australia & New Zealand midday

• 08:41 PM ET Jun 12, 2025
  

  Street Takeaways - Cochlear downgrades FY guidance (A$272.31, 0.00)

• 09:41 PM ET Jun 11, 2025
  

  Cochlear opens (8.4%), currently (0.8%) on downgraded FY NPAT guidance below consensus expectations (A$268.29, -2.17)

• 06:28 PM ET Jun 11, 2025
  

  Cochlear guides FY underlying NPAT A$390-400M vs prior guidance to lower end of A$410-430M and FactSet A$411.5M [10 est, A$406.8-414.9M] (A$270.46, 0.00)

• 06:55 PM ET Apr 08, 2025
  

  StreetAccount Market Summary - Impact of US tariffs in Australia

• 07:51 PM ET Apr 07, 2025
  

  Cochlear will continue to rely on the Harmonized Tariff Schedule that provides duty-free importation into the US, includes hearing implants (A$253.33, 0.00)

• 12:55 AM ET Apr 07, 2025
  

  StreetAccount Summary: Australia and New Zealand Stocks reaching new 52-week highs/lows (196 total)

• 06:53 PM ET Apr 02, 2025
  

  Cochlear awaits tariff clarification; notes import of its products into the US has historically been duty-free under a chapter of Harmonized Tariff Schedule (A$267.96, 0.00)

• 06:28 AM ET Mar 19, 2025
  

  Morgan Stanley initiates ANN.AU, COH.AU, CSL.AU, others